Carl Zeiss Meditec AG ADR
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $91.2
- Today's High:
- $92.98
- Open Price:
- $91.2
- 52W Low:
- $99.8093
- 52W High:
- $153.0187
- Prev. Close:
- $91.16
- Volume:
- 6906
Company Statistics
- Market Cap.:
- $10.62 billion
- Book Value:
- 21.84
- Revenue TTM:
- $2.02 billion
- Operating Margin TTM:
- 18.11%
- Gross Profit TTM:
- $1.13 billion
- Profit Margin:
- 13.76%
- Return on Assets TTM:
- 8.71%
- Return on Equity TTM:
- 14.98%
Company Profile
Carl Zeiss Meditec AG ADR had its IPO on under the ticker symbol CZMWY.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Carl Zeiss Meditec AG ADR has a staff strength of 4,624 employees.
Stock update
Shares of Carl Zeiss Meditec AG ADR opened at $91.2 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $91.2 - $92.98, and closed at $92.4.
This is a +1.36% increase from the previous day's closing price.
A total volume of 6,906 shares were traded at the close of the day’s session.
In the last one week, shares of Carl Zeiss Meditec AG ADR have slipped by -7.74%.
Carl Zeiss Meditec AG ADR's Key Ratios
Carl Zeiss Meditec AG ADR has a market cap of $10.62 billion, indicating a price to book ratio of 6.6377 and a price to sales ratio of 6.1706.
In the last 12-months Carl Zeiss Meditec AG ADR’s revenue was $2.02 billion with a gross profit of $1.13 billion and an EBITDA of $391.03 million. The EBITDA ratio measures Carl Zeiss Meditec AG ADR's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Carl Zeiss Meditec AG ADR’s operating margin was 18.11% while its return on assets stood at 8.71% with a return of equity of 14.98%.
In Q1, Carl Zeiss Meditec AG ADR’s quarterly earnings growth was a negative -31.7% while revenue growth was a positive 13.2%.
Carl Zeiss Meditec AG ADR’s PE and PEG Ratio
- Forward PE
- 39.8406
- Trailing PE
- 34.8167
- PEG
- 4.2332
Its diluted EPS in the last 12-months stands at $3.41 per share while it has a forward price to earnings multiple of 39.8406 and a PEG multiple of 4.2332. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Carl Zeiss Meditec AG ADR’s profitability.
Carl Zeiss Meditec AG ADR stock is trading at a EV to sales ratio of 6.7734 and a EV to EBITDA ratio of 34.5537. Its price to sales ratio in the trailing 12-months stood at 6.1706.
Carl Zeiss Meditec AG ADR stock pays annual dividends of $1.1 per share, indicating a yield of 1.02% and a payout ratio of 35.71%.
Balance sheet and cash flow metrics
- Total Assets
- $2.73 billion
- Total Liabilities
- $493.17 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 35.71%
Carl Zeiss Meditec AG ADR ended 2024 with $2.73 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.73 billion while shareholder equity stood at $1.96 billion.
Carl Zeiss Meditec AG ADR ended 2024 with $0 in deferred long-term liabilities, $493.17 million in other current liabilities, 89441000.00 in common stock, $1.23 billion in retained earnings and $399.66 million in goodwill. Its cash balance stood at $12.36 million and cash and short-term investments were $44.33 million. The company’s total short-term debt was $76,778,000 while long-term debt stood at $0.
Carl Zeiss Meditec AG ADR’s total current assets stands at $1.69 billion while long-term investments were $0 and short-term investments were $31.96 million. Its net receivables were $387.75 million compared to accounts payable of $192.46 million and inventory worth $441.41 million.
In 2024, Carl Zeiss Meditec AG ADR's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Carl Zeiss Meditec AG ADR paid $0.36 in dividends in 2024.
Other key metrics
- Current Trading Price
- $92.4
- 52-Week High
- $153.0187
- 52-Week Low
- $99.8093
- Analyst Target Price
- $
Carl Zeiss Meditec AG ADR stock is currently trading at $92.4 per share. It touched a 52-week high of $153.0187 and a 52-week low of $153.0187. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $105.49 and 200-day moving average was $125.42 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Carl Zeiss Meditec AG ADR
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers offers products and solutions for the diagnosis and treatment of chronic eye diseases; and systems and consumables for refractive surgery. This segment also provides slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras used for the examination of the retina in hospitals and practices; and equipment for functional diagnostics. In addition, this segment offers surgical microscopes, biometers, and phacoemulsification or vitrectomy devices; and intraocular lenses for cataract patients. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.